Interestingly, the DCM group exhibited a significant increase in cardiac NLRP3 inflammasome levels, by 3.2-fold, alongside a 2.9-fold elevation in IL-1β content compared to the normal control group. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.